These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 7514608

  • 1. SPARC is a source of copper-binding peptides that stimulate angiogenesis.
    Lane TF, Iruela-Arispe ML, Johnson RS, Sage EH.
    J Cell Biol; 1994 May; 125(4):929-43. PubMed ID: 7514608
    [Abstract] [Full Text] [Related]

  • 2. Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo.
    Iruela-Arispe ML, Lane TF, Redmond D, Reilly M, Bolender RP, Kavanagh TJ, Sage EH.
    Mol Biol Cell; 1995 Mar; 6(3):327-43. PubMed ID: 7612967
    [Abstract] [Full Text] [Related]

  • 3. Cleavage of the matricellular protein SPARC by matrix metalloproteinase 3 produces polypeptides that influence angiogenesis.
    Sage EH, Reed M, Funk SE, Truong T, Steadele M, Puolakkainen P, Maurice DH, Bassuk JA.
    J Biol Chem; 2003 Sep 26; 278(39):37849-57. PubMed ID: 12867428
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca(2+)-binding EF-hand sequence.
    Sage EH, Bassuk JA, Yost JC, Folkman MJ, Lane TF.
    J Cell Biochem; 1995 Jan 26; 57(1):127-40. PubMed ID: 7721952
    [Abstract] [Full Text] [Related]

  • 5. Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: characterization of the binding of vitronectin to osteonectin (BM40, SPARC).
    Rosenblatt S, Bassuk JA, Alpers CE, Sage EH, Timpl R, Preissner KT.
    Biochem J; 1997 May 15; 324 ( Pt 1)(Pt 1):311-9. PubMed ID: 9164872
    [Abstract] [Full Text] [Related]

  • 6. Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC.
    Chlenski A, Liu S, Baker LJ, Yang Q, Tian Y, Salwen HR, Cohn SL.
    Cancer Res; 2004 Oct 15; 64(20):7420-5. PubMed ID: 15492265
    [Abstract] [Full Text] [Related]

  • 7. Regulation of gene expression by SPARC during angiogenesis in vitro. Changes in fibronectin, thrombospondin-1, and plasminogen activator inhibitor-1.
    Lane TF, Iruela-Arispe ML, Sage EH.
    J Biol Chem; 1992 Aug 15; 267(23):16736-45. PubMed ID: 1379603
    [Abstract] [Full Text] [Related]

  • 8. Functional mapping of SPARC: peptides from two distinct Ca+(+)-binding sites modulate cell shape.
    Lane TF, Sage EH.
    J Cell Biol; 1990 Dec 15; 111(6 Pt 2):3065-76. PubMed ID: 2269665
    [Abstract] [Full Text] [Related]

  • 9. Antibodies to SPARC inhibit albumin binding to SPARC, gp60, and microvascular endothelium.
    Schnitzer JE, Oh P.
    Am J Physiol; 1992 Dec 15; 263(6 Pt 2):H1872-9. PubMed ID: 1481911
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts.
    Funk SE, Sage EH.
    J Cell Physiol; 1993 Jan 15; 154(1):53-63. PubMed ID: 8419407
    [Abstract] [Full Text] [Related]

  • 11. Specific interaction of SPARC with endothelial cells is mediated through a carboxyl-terminal sequence containing a calcium-binding EF hand.
    Yost JC, Sage EH.
    J Biol Chem; 1993 Dec 05; 268(34):25790-6. PubMed ID: 8245016
    [Abstract] [Full Text] [Related]

  • 12. The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells.
    Funk SE, Sage EH.
    Proc Natl Acad Sci U S A; 1991 Apr 01; 88(7):2648-52. PubMed ID: 2011576
    [Abstract] [Full Text] [Related]

  • 13. SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix.
    Sage H, Vernon RB, Funk SE, Everitt EA, Angello J.
    J Cell Biol; 1989 Jul 01; 109(1):341-56. PubMed ID: 2745554
    [Abstract] [Full Text] [Related]

  • 14. Secretion of SPARC by endothelial cells transformed by polyoma middle T oncogene inhibits the growth of normal endothelial cells in vitro.
    Sage EH.
    Biochem Cell Biol; 1992 Jul 01; 70(7):579-92. PubMed ID: 1449724
    [Abstract] [Full Text] [Related]

  • 15. SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells.
    Hasselaar P, Sage EH.
    J Cell Biochem; 1992 Jul 01; 49(3):272-83. PubMed ID: 1644864
    [Abstract] [Full Text] [Related]

  • 16. Secreted protein acidic and rich in cysteine (SPARC/osteonectin/BM-40) binds to fibrinogen fragments D and E, but not to native fibrinogen.
    Wang H, Workman G, Chen S, Barker TH, Ratner BD, Sage EH, Jiang S.
    Matrix Biol; 2006 Jan 01; 25(1):20-6. PubMed ID: 16263253
    [Abstract] [Full Text] [Related]

  • 17. SPARC mediates focal adhesion disassembly in endothelial cells through a follistatin-like region and the Ca(2+)-binding EF-hand.
    Murphy-Ullrich JE, Lane TF, Pallero MA, Sage EH.
    J Cell Biochem; 1995 Feb 01; 57(2):341-50. PubMed ID: 7539008
    [Abstract] [Full Text] [Related]

  • 18. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity.
    Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, Bouck N.
    J Cell Biol; 1993 Jul 01; 122(2):497-511. PubMed ID: 7686555
    [Abstract] [Full Text] [Related]

  • 19. Molecular analysis of chicken embryo SPARC (osteonectin).
    Bassuk JA, Iruela-Arispe ML, Lane TF, Benson JM, Berg RA, Sage EH.
    Eur J Biochem; 1993 Nov 15; 218(1):117-27. PubMed ID: 7916692
    [Abstract] [Full Text] [Related]

  • 20. Slow binding kinetics of secreted protein, acidic, rich in cysteine-VEGF interaction limit VEGF activation of VEGF receptor 2 and attenuate angiogenesis.
    Cydzik M, Abdul-Wahid A, Park S, Bourdeau A, Bowden K, Prodeus A, Kollara A, Brown TJ, Ringuette MJ, Gariépy J.
    FASEB J; 2015 Aug 15; 29(8):3493-505. PubMed ID: 25921830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.